GlassScriptPhysician profile
Todd M Wien
NPI 1265440275
$9,459.41
in general payments reported to CMS, 2019-2025
57 companies · $755 in 2025
The $755 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,808 · 2020: $470 · 2021: $1,311 · 2022: $2,056 · 2023: $1,558 · 2024: $1,502 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,814.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,388.72 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,037.62 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,012.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $812.04 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $650.66 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $418.73 | 2019-2024 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.57 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $339.83 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $273.53 | 2019-2022 | |
| Itamar Medical INC | $253.36 | 2022-2025 | Watchpatone |
| Pfizer INC. | $234.46 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $207.14 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.64 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $171.86 | 2020-2021 | |
| Exact Sciences Corporation | $146.98 | 2023-2024 | Cologuard Collection Kit |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Wien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.